Published in Obesity and Diabetes Week, August 15th, 2005
"Recent studies support the presence of an inflammatory response during the treatment of diabetic ketoacidosis. The objectives of this study were to monitor the complement activation products C3a, C4a, Bb, and C5b-9 prior to, during, and after correction of DKA," researchers in the United States reported.
"All patients had increased levels of C3a at 6-8 h and 24 h (p<0.05). C4a was increased in only one patient. Bb showed an upward trend at 6-8 h, and was significantly elevated at 24 h (p<0.05); sC5b-9 was elevated in all patients prior to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.